Latest article
Novo Nordisk presents trial outcomes of Xultophy for sort 2 diabetes
Novo Nordisk said Monday that its type 2 diabetes treatment Xultophy showed superior efficacy in reducing hemoglobin A1c (HbA1c) levels, weight change and lower...
Tandem Diabetes Care Publicizes Displays Demonstrating Quick and Sustained Actual-World Enhancements with Management-IQ Know-how
SAN DIEGO--(BUSINESS WIRE) - Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leader in insulin delivery and...
